Sanofi Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	46,716	44,286	41,618	40,561	39,175
Revenue Growth (YoY)	5.49%	6.41%	2.61%	3.54%	4.83%
Cost of Revenue	13,049	13,205	12,628	11,882	12,255
Gross Profit	33,667	31,081	28,990	28,679	26,920
Selling, General & Admin	9,543	9,183	8,933	8,739	9,555
Depreciation & Amortization Expenses	1,776	1,749	1,911	1,804	1,580
Research & Development	7,842	7,394	6,507	6,501	5,692
Other Operating Expenses	8,162	5,503	4,679	1,473	1,967
Total Operating Expenses	27,323	23,829	22,030	18,517	18,794
Operating Income	6,344	7,252	6,960	10,162	8,126
Interest Income	239	579	448	260	79
Interest Expense	-563	-1,073	-1,293	-430	-368
Total Non-Operating Income (Expense)	-324	-494	-845	-170	-289
Pretax Income	6,020	6,758	6,115	9,992	7,837
Provision for Income Taxes	1,043	1,204	1,017	1,909	1,558
Net Income	7,813	5,560	5,400	8,371	6,223
Minority Interest in Earnings	38	58	36	113	56
Earnings From Discontinued Operations	2,874	64	338	401	-
Net Income to Common	7,813	5,560	5,400	8,371	6,223
Net Income Growth	40.52%	2.96%	-35.49%	34.52%	-49.38%
Shares Outstanding (Basic)	2,441	2,503	2,503	2,504	2,505
Shares Outstanding (Diluted)	2,451	2,512	2,513	2,514	2,516
Shares Change (YoY)	-2.43%	-0.02%	-0.04%	-0.08%	-0.18%
EPS (Basic)	3.20	2.22	2.15	3.35	2.48
EPS (Diluted)	3.19	2.21	2.15	3.33	2.48
EPS Growth	43.79%	3.02%	-35.44%	34.54%	-49.28%
Free Cash Flow	7,212	5,886	7,352	8,423	8,479
Free Cash Flow Growth	22.53%	-19.94%	-12.72%	-0.66%	58.93%
Free Cash Flow Per Share	2.94	2.34	2.93	3.35	3.37
Dividends Per Share	4.120	3.920	3.760	3.560	3.330
Dividend Growth	5.10%	4.25%	5.62%	6.91%	4.06%
Gross Margin	72.07%	70.18%	69.66%	70.71%	68.72%
Operating Margin	13.58%	16.38%	16.72%	25.05%	20.74%
Profit Margin	10.65%	12.54%	12.25%	19.93%	16.03%
FCF Margin	15.44%	13.29%	17.67%	20.77%	21.64%
EBITDA	12,022	10,838	11,389	13,270	11,477
EBITDA Margin	25.73%	24.47%	27.37%	32.72%	29.30%
EBIT	6,344	7,252	6,960	10,162	8,126
EBIT Margin	13.58%	16.38%	16.72%	25.05%	20.74%
Effective Tax Rate	17.33%	17.82%	16.63%	19.11%	19.88%

Updated Jan 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q